Sorin Group makes another equity investment in Enopace Biomedical, gets option to buy
Sorin Group SPA has made another minority equity investment in Enopace Biomedical Ltd. and received an option to buy the company, which is focused on neuromodulation system for heart failure patients.
- Medical Devices
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Includes Equity
- Includes M&A Option
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.